Prolonged Remission in Chronic Myeloid Leukemia after One Course of Busulfan
Open Access
- 1 January 1966
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 27 (1) , 103-109
- https://doi.org/10.1182/blood.v27.1.103.103
Abstract
A patient with chronic myeloid leukemia in whom a clinical and hematologic remission of nearly 7 years duration occurred after a single short course of busulfan is described. The only abnormal finding during the remission was a negative alkaline phosphatase reaction in her leukocytes. Chromosomal studies prior to relapse revealed a normal karyotype, and no Philadelphia chromosome was found. During relapse renewed chromosomal study revealed Philadelphia chromosome in metaphases of peripheral blood leukocytes.This publication has 6 references indexed in Scilit:
- Busulphan in the Treatment of Chronic Granulocytic LeukaemiaBritish Journal of Cancer, 1961
- Leukocytic Alkaline Phosphatase in Busulfan Induced Remissions of Chronic Granulocytic LeukemiaBlood, 1961
- BUSULFAN (1,4‐DIMETHANESULFONYLOXYBUTANE, MYLERAN): SUMMARY OF CLINICAL, RESULTSAnnals of the New York Academy of Sciences, 1958
- Myleran Treatment in Chronic Granulocytic LeukaemiaBritish Journal of Haematology, 1957
- Leukocytic Alkaline PhosphataseBlood, 1957
- Treatment of Chronic Granulocytic Leukemia with 1,4-Dimethanesulfonyloxybutane (Myleran)New England Journal of Medicine, 1956